Letko, Brosseau & Associates’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-73,659
Closed -$147K 101
2022
Q3
$147K Hold
73,659
﹤0.01% 95
2022
Q2
$55K Hold
73,659
﹤0.01% 99
2022
Q1
$641K Hold
73,659
0.01% 88
2021
Q4
$1.18M Hold
73,659
0.02% 87
2021
Q3
$1.36M Hold
73,659
0.02% 88
2021
Q2
$1.03M Hold
73,659
0.01% 90
2021
Q1
$1.08M Buy
73,659
+5,559
+8% +$81.8K 0.01% 87
2020
Q4
$1.32M Buy
+68,100
New +$1.32M 0.02% 87